Assembly Biosciences, Inc.
ASMB· Nasdaq
Released Aug 9, 2023, after the close
10-Q filed Aug 9, 2023, 40 days after period end · 0000950170-23-040626
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | $39.38M |
| Net Income | -$16.90M | -$24.46M | -$23.60M | $7.27M |
| EPS Diluted |
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR
| -$3.88 |
| -$0.51 |
| -$0.55 |
| $0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.